Alpha-9 Oncology Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Alpha-9 Oncology is a clinical-stage biotechnology company focused on radiopharmaceuticals designed to target tumors with radiation while limiting exposure to healthy tissue. Based in Boston, Massachusetts, the company aims to advance cancer treatment by delivering radiotherapy more selectively to tumor sites. Its pipeline comprises novel radiopharmaceutical candidates developed through a structured design approach that supports expansion across multiple oncology targets. The company was founded by researchers from the University of British Columbia and BC Cancer, grounding its origins in academic and clinical collaboration. The company is a small biotechnology organization. In October 2025, Paul Blanchfield was appointed chief executive officer.